scholarly journals Central Venous Access Devices (CVAD) in Pediatric Oncology Patients—A Single-Center Retrospective Study Over More Than 9 Years

2019 ◽  
Vol 7 ◽  
Author(s):  
Olaf Beck ◽  
Oliver Muensterer ◽  
Sarah Hofmann ◽  
Heidi Rossmann ◽  
Alicia Poplawski ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Pediatric Oncology ◽  
Central Venous Access ◽  
Venous Access ◽  
Single Center ◽  
Central Venous ◽  
Oncology Patients ◽  
Venous Access Devices

Usefulness of Totally Implantable Central Venous Access Devices in Elderly Patients: A Retrospective Study

2018 ◽  
Vol 72 (2) ◽  
pp. 112-116
Author(s):  
Yuki Imaoka ◽  
Fumito Kuranishi ◽  
Yoshiteru Ogawa
Keyword(s):  
Retrospective Study ◽  
Central Venous Access ◽  
Prognostic Nutritional Index ◽  
Venous Access ◽  
Solid Organ ◽  
Central Venous ◽  
Significant Group ◽  
Study Support ◽  
Onodera’S Prognostic Nutritional Index ◽  
Venous Access Devices

Background/Aims: The need for totally implantable central venous access devices (TICVADs) has increased with increased opportunities in the use of chemotherapy and parenteral nutrition. This study aimed to determine the outcomes of TICVAD implantation and use in patients aged ≥85 years. Methods: Between January 2010 and August 2016, 117 patients underwent TICVAD implantation and their records were retrospectively reviewed. Results: Participants were divided into 2 groups (plus-85 and sub-85 groups). Fifty-five patients (47.0%) had solid organ cancer alone; 35 patients (29.9%) had cerebrovascular or cranial nerve disease. The average follow-up period was 201 (2–1,620) days. Major complications were identified in 6 (14.6%) plus-85 patients and 11 (14.5%) sub-85 patients (p = 0.9813). Catheter-related infections developed in 3 plus-85 (7.3%) and 4 sub-85 patients (5.3%; p = 0.6549). There were no significant group differences in hematoma, pneumothorax, occlusion, and removal rates. In plus-85 patients examined just before surgery and a month after surgery, increased rates of serum albumin and Onodera’s prognostic nutritional index were observed in 48% (14/39) and 41% (12/39), respectively. Conclusions: The use of TICVADs in the plus-85 group resulted in effective outcomes. The results of this retrospective study support the wider use of TICVADs in patients aged ≥85 years.

Effect of a Nurse-Led Protocol on Time to Treatment of Partial Occlusions in Central Venous Access Devices in Pediatric Oncology

2020 ◽  
Vol 37 (5) ◽  
pp. 305-312
Author(s):  
Allison Hunter ◽  
K. Shantel Cunningham ◽  
Carol Yuen ◽  
Kristen Jensen ◽  
Arfan Afzal ◽  
...  
Keyword(s):  
Life Span ◽  
Pediatric Oncology ◽  
Prospective Cohort ◽  
Retrospective Cohort ◽  
Dwell Time ◽  
Central Venous Access ◽  
Venous Access ◽  
Central Venous ◽  
Time To Treatment ◽  
Venous Access Devices

Central venous access devices (CVADs) are the standard of care in pediatric oncology. Occlusion is a common complication that can lead to delays in therapy, readmission, and CVAD removal and reinsertion. Early treatment of partial occlusions using a standardized protocol may restore patency and increase life span of CVADs. The objective of this study was to develop and evaluate a nurse-led protocol to manage partial CVAD occlusions in pediatric oncology and autologous bone marrow transplant patients. The protocol enabled nurses to manage partially occluded CVADs by administering thrombolytic therapy following an algorithm and patient-specific standing order. The primary outcome was time from recognition of the partial occlusion to instillation of a thrombolytic. Secondary outcomes were thrombolytic dwell time, number of complete occlusions, and CVAD life span. We used a quasi-experimental, after-only, nonequivalent control group design to compare patients not exposed (retrospective cohort, n = 137) and patients exposed (prospective cohort, n = 101) to the nurse-led protocol. Mann–Whitney U tests were used to compare time to treatment, dwell time, and CVAD life span between cohorts, and χ2 was used to compare the proportion of occlusions classified as complete. Time to treatment was significantly lower in the prospective cohort ( M = 99.9 minutes) versus the retrospective cohort ( M = 483.7 minutes), U = 1366.50, p < .01, as was thrombolytic dwell time, U = 282.50, p < .01. Proportion of complete occlusions and CVAD life span did not differ between cohorts. The nurse-led protocol was effective to manage partial CVAD occlusions in pediatric oncology patients.

scholarly journals An audit of central venous access devices (CVADs) in pediatric oncology

2016 ◽  
Vol 1 (2) ◽  
pp. S32-S33
Author(s):  
Deepankar Bhattacharya ◽  
Shalini Mishra ◽  
Sandeep Jain ◽  
Gauri Kapoor
Keyword(s):  
Pediatric Oncology ◽  
Central Venous Access ◽  
Venous Access ◽  
Central Venous ◽  
Venous Access Devices

Totally implantable central venous access devices for paediatric oncology patients

1999 ◽  
Vol 33 (4) ◽  
pp. 377-381 ◽  
Author(s):  
F.D. Munro ◽  
P.M. Gillett ◽  
J.C. Wratten ◽  
M.P. Shaw ◽  
A. Thomas ◽  
...  
Keyword(s):  
Central Venous Access ◽  
Venous Access ◽  
Paediatric Oncology ◽  
Central Venous ◽  
Oncology Patients ◽  
Venous Access Devices
Sign in / Sign up

Export Citation Format

Share Document